***rocketting on announcement, page-4

Nice to see a bit of interest in the options for a change. Looking forward to the action once the company achieves cash flow positive status! :)
Worth noting that Pfizer are due to commercialise inhaled insulin this year. Can potentially open the funhaler market up further along with comforting the children who unfortunately suffer from diabetes.

Cheers,
xmagx